Journal of Rawalpindi Medical College,
Journal Year:
2023,
Volume and Issue:
27(4)
Published: Dec. 30, 2023
Objective:
The
purpose
of
this
research
was
to
determine
the
incidence
Acute
Kidney
Injury
(AKI)
in
COVID-19-affected
patients
Methods:
This
retrospective
cohort
study
conducted
at
Ziauddin
Hospital
Clifton
Campus
from
June
December
2020.
Adult
with
AKI
or
acute-on-chronic
kidney
disease
(ACKD)
were
included
a
study.
Patients
infected
SARS-CoV2
and
renal
involvement
directed
towards
ICU/Nephrology
departments
which
have
expertise
perform
laboratory
analysis,
radiography
institution
treatment.
Supplemental
oxygen
use
documented.
also
assessed
information
about
therapy
(antivirals,
immunomodulators,
RRT)
results
(renal
function
recovery
death).
Results:
After
excluding
obstructive
AKI,
total
180
(mean
age
50.1
years)
104
males
76
females
research.
120
found
prerenal,
60
had
intrinsic
significant
differences
between
mild,
moderate,
severe
cases
(p=0.004).
injury
survivors
complete
rate
70%,
partial
22%,
hemodialysis
dependency
8%.
Conclusion:
COVID-19
infection
often
develop
more
those
critical
stages
exhibit
proteinuria
dipstick
hematuria.
Long-term
follow-up
for
should
be
done
evaluate
its
influence
on
outcome,
larger
samples
are
required
elucidate
association
damage.
Keywords:
Coronavirus
Disease,
Renal
Replacement
Therapy,
proteinuria,
hematuria
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(3), P. 579 - 579
Published: Feb. 25, 2025
Background:
Although
autoimmune
complications
of
COVID-19
have
aroused
concerns,
there
is
no
consensus
on
its
ocular
complications.
Sjögren’s
syndrome
an
disease
accompanied
by
the
abnormality
keratoconjunctivitis
sicca
(SS-KCS),
which
may
be
influenced
COVID-19.
Thereby,
we
explored
possible
interaction
between
and
SS-KCS,
aimed
to
elucidate
potential
correlated
mechanism.
Methods:
Differentially
expressed
genes
(DEGs)
in
SS-KCS
transcriptome
data
obtained
from
gene
expression
omnibus
database
were
identified,
COVID-19-related
screened
using
weighted
coexpression
network
analysis.
Common
verified
four
machine-learning
diagnostic
predictors.
The
clinical
relationship
two
common
hub
was
analyzed.
Finally,
immune
cell
types
infiltrating
microenvironment
dataset
analyzed
CIBERSORT,
interrelation
key
differentially
cells
via
Pearson
correlation.
Results:
Ten
primary
mRNAs
intersecting
DEGs,
WGCNA
genes.
After
a
multifaceted
evaluation
mainstream
predictors,
most
accurate
sensitive
random
forest
model
identified
CR1
TAP2
as
SS-KCS.
Together
with
information
COVID-19,
significantly
status
severity
positively
M0
M2
macrophages,
neutrophils,
CD4+
memory
resting
T
negatively
activated
NK
cells,
monocytes,
CD8+
cells.
Conclusions:
We
validated
associated
both
investigated
mechanisms
underlying
their
interaction,
help
early
prediction,
identification,
diagnosis,
management
SARS-CoV-2
infection-related
or
many
other
immune-related
long
COVID
period.
Journal of Biological Chemistry,
Journal Year:
2023,
Volume and Issue:
299(11), P. 105341 - 105341
Published: Oct. 12, 2023
The
emergence
of
severe
acute
respiratory
syndrome
coronavirus
2,
the
causative
agent
disease
2019,
has
resulted
in
largest
pandemic
recent
history.
Current
therapeutic
strategies
to
mitigate
this
have
focused
on
development
vaccines
and
drugs
that
inhibit
viral
3CL
protease
or
RNA-dependent
RNA
polymerase
enzymes.
A
less-explored
potentially
complementary
drug
target
is
Nsp15,
a
uracil-specific
endonuclease
shields
coronaviruses
other
nidoviruses
from
mammalian
innate
immune
defenses.
Here,
we
perform
high-throughput
screen
over
100,000
small
molecules
identify
Nsp15
inhibitors.
We
characterize
potency,
mechanism,
selectivity,
predicted
binding
mode
five
lead
compounds.
show
one
these,
IPA-3,
an
irreversible
inhibitor
might
act
via
covalent
modification
Cys
residues
within
Nsp15.
Moreover,
demonstrate
three
these
inhibitors
(hexachlorophene,
CID5675221)
block
2
replication
cells
at
subtoxic
doses.
This
study
provides
pipeline
for
identification
pinpoints
compounds
further
against
2019
related
infections.
Frontiers in Bioscience-Landmark,
Journal Year:
2024,
Volume and Issue:
29(1), P. 8 - 8
Published: Jan. 12, 2024
Kidney
damage
in
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
can
occur
even
patients
with
no
underlying
kidney
disease.
Signs
of
problems
progress
to
a
state
that
demands
dialysis
and
hampering
recovery.
Although
not
without
controversy,
emerging
evidence
implicates
direct
infectivity
SARS-CoV-2
the
kidney.
At
early
stage
pandemic,
consideration
was
mainly
on
well-recognized
angiotensin-converting
enzyme
(ACE2)
receptor
as
being
site
for
viral
interaction
subsequent
cellular
internalization.
Despite
abundance
ACE2
receptors
kidneys,
researchers
have
expanded
beyond
identified
novel
entry
pathways
could
be
advantageously
explored
therapeutic
targets.
This
review
presents
potential
involvement
toll-like
4
(TLR-4),
injury
molecule-1/T
cell
immunoglobulin
mucin
domain
1
(KIM-1/TIM-1),
cluster
differentiation
147
(CD147)
SARS-CoV-2-associated
renal
damage.
In
this
context,
we
address
unresolved
issues
surrounding
infectivity.
Journal of Biosciences and Medicines,
Journal Year:
2023,
Volume and Issue:
11(09), P. 90 - 113
Published: Jan. 1, 2023
Long
COVID
has
been
studied
as
different
sequelae
that
some
individuals
can
develop
after
the
acute
phase
of
disease.
Persistent
symptoms
such
dry
cough,
fatigue,
and
dyspnea
remain
six
months
COVID-19
cure.
Others
lung
fibrosis,
kidney
injury,
thrombotic
risk
also
are
observed.
Here,
a
deep
review
each
human
organ
system
infected
by
virus
was
performed
aiming
to
show
how
molecules
expression
cell
signaling
induce
organism
cure
or
injuries
and,
subsequently
sequelae.
The
suggests
importance
public
health
surveillance
for
these
cases
including
more
comprehensive
analysis
molecular
biology
tools
clarify
assist
in
prognosis,
treatment,
preventive
methods
potentially
serious
disorders
post-COVID-19
patients.
Journal of Zhejiang University (Medical Sciences),
Journal Year:
2023,
Volume and Issue:
52(5), P. 594 - 604
Published: Sept. 28, 2023
To
explore
the
mechanism
of
transforming
growth
factor-β1
(TGF-β1)
induce
renal
fibrosis.Renal
fibroblast
NRK-49F
cells
treated
with
and
without
TGF-β1
were
subjected
to
RNA-seq
analysis.
DESeq2
was
used
for
Differentially
expressed
genes
screened
criteria
false
discovery
rate<0.05
l
o
g
2
F
C
>1.
Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
enrichment
analyses
performed
differentially
genes.
encoding
transcription
factors
further
differential
expression
Then,
these
during
fibrosis
verified
using
unilateral
ureteral
obstruction
(UUO)-induced
mouse
model
a
public
gene
dataset
(GSE104954).After
treatment
6,
12
24
h,
552,
1209
1028
identified,
respectively.
GO
analysis
indicated
that
significantly
enriched
in
development,
cell
death,
migration.
KEGG
showed
early
stage
induction
(TGF-β1
6
h),
changes
Hippo,
TGF-β
Wnt
signaling
pathways
observed,
while
late
extracellular
matrix-receptor
interaction,
focal
adhesion
adherens
junction
mainly
enriched.
Among
291
up-regulated
13
(Snai1,
Irf8,
Bhlhe40,
Junb,
Arid5a,
Vdr,
Lef1,
Ahr,
Foxo1,
Myc,
Tcf7,
Foxc2,
Glis1)
encoded
factors.
Validation
induced
9
(encoded
by
Snai1,
Tcf7),
levels
other
4
did
not
change
after
treatment.
results
UUO-induced
Myc
Tcf7
UUO,
Vdr
down-regulated
there
no
significant
Lef1.
based
on
GSE104954
IRF8
overexpressed
tubulointerstitium
patients
diabetic
nephropathy
or
IgA
nephropathy,
MYC
highly
expressions
7
different
compared
control
group.TGF-β1
induces
fibroblasts,
among
which
Irf8
identified
as
potential
targets
chronic
kidney
disease
fibrosis.目的:
探究转化生长因子-β1(TGF-β1)诱导肾纤维化的机制。方法:
将TGF-β1处理和未处理的肾成纤维细胞NRK-49F进行转录组测序,采用DESeq2分析测序结果,以错误发现率低于0.05且log2FC绝对值大于1为标准筛选差异表达的基因,并对差异表达的基因进行基因本体(GO)、京都基因和基因组百科全书(KEGG)通路富集分析。进一步筛选差异表达基因中编码转录因子的基因,并利用单侧输尿管梗阻诱导的小鼠肾纤维化模型和高通量基因表达数据库GSE104954数据集对这些基因在肾纤维化过程中的表达进行验证。结果:
TGF-β1处理6、12和24
h后,分别有552、1209和1028个差异表达基因。GO分析表明,这些差异表达基因在发育、细胞死亡和细胞迁移过程中显著富集。KEGG分析显示,在TGF-β1诱导早期(TGF-β1处理6
h)主要表现为Hippo、TGF-β、Wnt信号通路的变化,而在TGF-β1诱导晚期(TGF-β1处理24
h)主要表现为细胞外基质受体相互作用、局灶黏附和黏附分子连接等相关通路的改变。在TGF-β1处理6
h时291个上调的差异表达基因中,Snai1、Irf8、Bhlhe40、Junb、Arid5a、Vdr、Lef1、Ahr、Foxo1、Myc、Tcf7、Foxc2、Glis1等13个基因编码转录因子。在细胞模型中验证发现,TGF-β1可以诱导其中9个编码转录因子基因(Snai1、Irf8、Bhlhe40、Junb、Arid5a、Vdr、Lef1、Myc、Tcf7)的表达,其余4个基因的表达水平在TGF-β1处理后无显著变化。在动物模型验证中发现,Snai1、Irf8、Bhlhe40、Junb、Arid5a、Myc和Tcf7显著上调,而Vdr显著下调,Lef1无显著变化。在GSE104954数据集中验证发现,IRF8在糖尿病肾病患者和IgA肾病患者的肾小管间质中显著高表达,MYC在糖尿病肾病患者中高表达,而其他7个基因的表达产物与对照组相似。结论:
TGF-β1诱导肾成纤维细胞基因差异表达,Irf8和Myc可能是慢性肾脏病和肾纤维化的潜在靶点。.